Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism (R21AA026388, U10AA008401)
U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism
Received: 3 November 2020
Accepted: 3 August 2021
First Online: 20 August 2021
: Alison Goate is on the scientific advisory board for Genentech and has served as a consultant for AbbVie and Cognition Therapeutics. Alison Goate is also listed as an inventor on Issued U.S. Patent 8,080,371, “Markers for Addiction” covering the use of certain variants in determining the diagnosis, prognosis, and treatment of addiction. From February, 2021, Manav Kapoor is employee of Regeneron Pharmaceuticals. All other authors declare no competing interest.